ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Henderson Committee Final Recommendation Made On P01s

February 10, 1984

CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments

January 8, 1982

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989

Firm Reports Limited Market For Self-Test Detection Methods

July 29, 1983

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

Avastin Regimen Bested Chemo Alone In Early Disease

January 31, 2003